In: Tropical Medicine & International Health. Unidade: ICB
Subjects: Parasitologia, Leishmaniose Cutânea
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Paulo R. L.; RIBEIRO, Camila S.; FRANÇA‐COSTA, Jaqueline; et al. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial. Tropical Medicine & International Health, West Sussex, Wiley-Blackwell Publishing Ltd, v. 23, n. 9, p. 936-942, 2018. Disponível em: < https://doi.org/10.1111/tmi.13119 > DOI: 10.1111/tmi.13119.APA
Machado, P. R. L., Ribeiro, C. S., França‐Costa, J., Dourado, M. E. F., Trinconi, C. T., Yokoyama‐Yasunaka, J. K. U., et al. (2018). Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial. Tropical Medicine & International Health, 23( 9), 936-942. doi:10.1111/tmi.13119NLM
Machado PRL, Ribeiro CS, França‐Costa J, Dourado MEF, Trinconi CT, Yokoyama‐Yasunaka JKU, Malta‐Santos H, Borges VM, Carvalho EM, Uliana SRB. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial [Internet]. Tropical Medicine & International Health. 2018 ; 23( 9): 936-942.Available from: https://doi.org/10.1111/tmi.13119Vancouver
Machado PRL, Ribeiro CS, França‐Costa J, Dourado MEF, Trinconi CT, Yokoyama‐Yasunaka JKU, Malta‐Santos H, Borges VM, Carvalho EM, Uliana SRB. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial [Internet]. Tropical Medicine & International Health. 2018 ; 23( 9): 936-942.Available from: https://doi.org/10.1111/tmi.13119
